A gene-environment-induced epigenetic program initiates tumorigenesis

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Tissue damage is a known risk factor for cancer, but the underlying mechanisms remain unclear.
• In pancreatic cancer, pancreatitis and Kras oncogene mutations accelerate tumor formation.
• Understanding gene-environment interactions is crucial for cancer initiation research.

Purpose of the Study:

• To investigate how Kras mutations and tissue damage interact to promote pancreatic cancer.
• To identify the early molecular and epigenetic changes driving neoplastic transformation.
• To elucidate the role of specific signaling pathways, like interleukin 33, in cancer initiation.

Main Methods:

• Utilized autochthonous mouse models of pancreatic cancer.
• Integrated genomics, single-cell chromatin assays, and functional perturbations.
• Analyzed spatiotemporal changes in pancreatic epithelium following injury and Kras mutation.

Main Results:

• Kras mutation and tissue damage induce a distinct chromatin state in pancreatic epithelium, differentiating neoplasia from regeneration.
• This 'acinar-to-neoplasia' chromatin switch occurs within 48 hours of injury, dysregulating key cancer-associated genes.
• Interleukin 33 is rapidly activated post-injury and cooperates with mutant Kras to drive epigenetic reprogramming and neoplastic transformation.

Conclusions:

• Gene-environment interactions rapidly establish gene-regulatory programs that commit cells to neoplastic development.
• A molecular framework is provided for understanding how genetic and environmental factors initiate pancreatic cancer.
• The study highlights the critical role of epigenetic alterations in early cancer development.